Cagrilintide + Semaglutide 5MG
$125.00
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of cagrilintide, an amylin analogue peptide, and semaglutide, a GLP 1 receptor agonist peptide analogue derived from glucagon like peptide 1 research. This combination is of interest in research exploring complementary gut brain signaling pathways involved in satiety, gastric emptying, and glucose related endpoints.
Studies have examined cagrilintide and semaglutide together in the context of appetite regulation and energy balance, using hedged interpretations of how dual pathway engagement may influence measured outcomes in controlled settings. Cagrilintide + Semaglutide 5MG may be used by researchers who require both peptide identities in a single specified format for experimental design and comparative work.
- Specification: 5MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Semaglutide 15MG is a 15-milligram format of semaglutide, a synthetic peptide analogue of the endogenous incretin hormone GLP 1. Researchers study semaglutide as a GLP 1 receptor agonist in models of glucose regulation, appetite signaling, and cardiometabolic physiology.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.
In Stock
Tirzepatide 30MG is a 30-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glucose regulation pathways, and energy balance models.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Trenbolone Acetate 75Mg, Trenbolone Enanthate 125Mg – 200mg/ml, 10 ml is a combined format of trenbolone in two ester forms: acetate and enanthate. Trenbolone is a synthetic anabolic androgenic steroid derived from 19-nortestosterone and widely referenced in endocrine and receptor binding research. Studies have examined esterified trenbolone in the context of androgen receptor signaling, pharmacokinetics, and steroid structure activity relationships.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock
Winstrol 50mg/ml 10ml refers to a 50 milligram per millilitre, 10 millilitre format commonly associated with stanozolol, a synthetic anabolic androgenic steroid. In research settings, stanozolol has been examined for its interactions with androgen receptor signaling and anabolic androgenic structure activity relationships. Studies have also used it as a reference compound in analytical and anti doping method development.
In Stock
Cagrilintide 5MG is a 5-milligram format of cagrilintide, a long acting amylin analogue peptide engineered for extended receptor activity. Researchers study amylin analogues in the context of metabolic signaling, appetite regulation pathways, and gastric emptying models.
In Stock
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
Semaglutide 5MG is a 5-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied as an acylated peptide engineered for extended stability in biological systems. Researchers have examined semaglutide in preclinical and translational work involving incretin signaling and metabolic regulation pathways.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
